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Mechanical function and coronary hemodynamics were assessed in 73 isolated 
rabbit hearts randomly subjected to 0, 10, 20, 30, or 45 minutes of 37 ° C global 
ischemia and 45 minutes of reperfusion in eitber a modified Krebs buffer or 
homologous blood-perfused Langendorff mode (n = 7 to 9 hearts per group). 
Isovolumic developed pressure, resting coronary flow, and response to endothelium- 
dependent (bradykinin) and -independent (nitroglycerin) agonists were quantitated 
at defined preload and heart rate. Perfusate did not influence systolic performance, 
which was impaired after 30 minutes of ischemia and fell to 64% to 72% of 
preischemic values after 45 minutes of ischemia (p < 0.05). However, basal coronary 
flow was at least sixfold greater in crystalloid-perfused hearts. Moreover, coronary 
hyperemia (p < 0.05) persisted for Krebs-perfused hearts subjected to all but the 
longest ischemic interval. After equilibration, all postischemic blood-perfused 
hearts had basal flow unchanged from before ischemia. Bradykinin and nitroglyc- 
erin induced similar increases in coronary flow for each group before and after each 
ischemia interval. However, the magnitude of this increase was greater in blood- 
perfused hearts (p < 0.01) and was not attenuated by the ischemic times encom- 
passed in this protocol. In contrast, endothelium-dependent and -independent 
coronary flow reserve was abolished after 20 minutes of ischemia or longer in 
Krebs-perfused hearts. These data suggest that the unphysiologic resting flow 
patterns of crystalloid-perfused isolated hearts obfuscate interpretation of the 
interaction between coronary flow reserve and ischemic injury. (J THORAC CARDIO- 
VASC SURG 1995;109:466-72) 
Quanmei Deng, MD, a Alfonso G. Scicli, PhD, b Carol Lawton, BS, a 
and Norman A. Silverman, MD, a Detroit, Mich. 
T he isolated, perfused, small animal heart has been a standard experimental model for quanti- 
tating the consequences of ischemia and reperfu- 
sion. Although the focus of previous investigations 
has historically been on myocyte viability as assessed 
by postischemic ventricular performance and car- 
diac metabolism, the coronary arterial smooth mus- 
cle and the endothelium with its paracrine function 
are now recognized as separate and important 
considerations in formulating strategies to prevent 
ischemia-reperfusion injury. 1"2 Crystalloid-perfused 
heart preparations have the advantages of lower 
cost, precision of formulation, simplicity, and avoid- 
ance of thrombus formation. However, clinical rel- 
evance will always be questionable because the roles 
of erythrocytes, platelets, and leukocytes in oxida- 
tive stress and reperfusion i jury are excluded. Also, 
the lack of plasma proteins results in osmotic and 
oncotic inadequacies and the baseline high oxygen 
tension and coronary flow rate are unphysiologic. 3 
The present study was designed to quantitate and 
compare perturbations in basal coronary flow and 
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coronary hemodynamics stimulated by endotheli- 
um-dependent and endothelium-independent ago- 
nists after progressively severe, reversible ischemic 
insults in crystalloid- and blood-perfused isolated 
hearts. These observations suggest hat the unphys- 
iologic resting flow patterns attendant to asanguin- 
eous perfusates obfuscate interpretation of coronary 
flow reserve after ischemic injury. 
Materials and methods 
Langendorff perfusion. The details of the blood-per- 
fused ex vivo preparation have been previously described. 4 
All animals received humane care in compliance with the 
"Principles of Laboratory Animal Care" formulated by 
the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
prepared by the National Academy of Sciences and pub- 
lished by the National Institutes of Health (NIH Publica- 
tion No. 80-23, revised 1978). Adult New Zealand White 
rabbits (2.5 to 3.8 kg) were anesthetized, heparinized, a 
tracheostomy performed, and the lungs ventilated with 
room air. The abdomen of the blood-donor rabbit was 
opened and the abdominal aorta was cannulated with an 
18-gauge ball-end needle for blood collection. The thorax 
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Table I. Systolic performance during the experimental protocol 
After ischemia 
Before ischemia 10 min 20 min 30 min 45 min 
DP (mm Hg) 
Krebs 110 -2_ 6 117 ± 3 107 ± 10 79 -4- 6" 70 +- 8* 
Blood 97 -+ 4 119 _+ 11 84 -- 11 72 ± 8* 70 -+ 9* 
+dp/dt (mm Hg sec -1) 
Krebs 1556 +- 133 1662 ± 77 1443 ± 236 1228 -+ 150 977 -+ 180" 
Blood 1461 -+ 99 1401 ± 109 1302 +_ 299 1262 _+ 155 1052 _+ 286* 
Values are mean -+ standard error of the mean; n = 7 to 9 hearts per group; DP, Developed pressure. 
*p < 0.05 versus before ischemia. 
and abdomen of the heart-donor rabbit were opened. 
Both the abdominal aorta and ascending aorta were 
cannulated in situ and retrograde perfusion was initiated 
before the heart was harvested as blood was withdrawn 
and added to the venous reservoir. The pulmonary artery 
was cannulated for collection and measurement of coro- 
nary effluent. The heart was then harvested and mounted 
on the siliconized glass perfusion column. Normothermic 
retrograde perfusion was initiated at 50 mm Hg for 5 
minutes and then increased to 80 mm Hg by varying the 
speed of the roller pump. The blood perfusate was 
oxygenated by bubbling the reservoir beaker with a mix- 
ture of 95% oxygen and 5% carbon dioxide to maintain 
oxygen tension between 120 and 200 torr and carbon 
dioxide tension between 35 and 45 torf. The pH was 
eorrected to 7.35 to 7.45 with sodium bicarbonate. Crys- 
talloid-perfused hearts were similarly cannulated and per- 
fused in situ before being mounted to minimize ischemia. 
Hearts did not stop beating in the interval between 
harvesting and mounting. The modified Krebs buffer 
solution was bubbled with a 95% oxygen and 5% carbon 
dioxide mixture. The blood perfusion was a recirculating 
system whereas the Krebs perfusate was not recirculated. 
All hearts were immersed in a water-jacketed organ 
ehamber to maintain a temperature of 37 ° C. During 
stabilization after retrograde perfusion was established, 
the venae cavae were ligated, the sinus node crushed, the 
lungs removed, and all hearts were instrumented in the 
following manner. The left atrium was opened and a size 
10 intraventricular latex balloon (Hugo Sachs Elektronik, 
March-Hugstetten, Germany) secured below the mitral 
anulus. A 1 mm diameter plastic catheter effeeted left 
ventricular venting. A saline filled Tygon microbore tube 
(Norton Performance Plastics, Wayne, N.J.) connected 
the balloon to a P23XL transducer (Viggo-Spectramed, 
Inc., Sacramento, Calif.) for measurement of left ventric- 
ular pressure, developed pressure, and the rate of positive 
and negative pressure development (±dp/dt). Pressure 
tracings were recorded on an eight-channel recorder (RS 
3800, Gould, Inc., Cleveland, Ohio). Ventricular elec- 
trodes were attached and the hearts paced at 180 beats/ 
min. For the purpose of drug testing, the bolus infusion 
was administered through a sidearm line to the main 
perfusion line. 
Experlmental protoeol. Hearts were perfused with ei- 
ther oxygenated Krebs buffer or homologous blood and 
randomly subjected to 10, 20, 30, or 45 minutes of 37 ° C 
global ischemia effected by stopping the perfusion pump. 
Control hearts were studied without antecedent ischemia. 
After a 45-minute equilibration time with retrograde 
perfusion, baseline isovolumic systolic function and coro- 
nary flow were quantitated at the fixed paced rate and an 
end-diastolic pressure of 10 mm Hg. Endothelium-depen- 
dent coronary flow reserve was quantitated after bolus 
infusion of 1 ml 10 -6  molar bradykinin. A 12-minute 
washout period allowed resting coronary flow to return to 
baseline before endothelium-independent coronary flow 
reserve was quantitated by bolus infusion of 500 tzg 
nitroglycerin. Hearts were then removed from the perfu- 
sion column, excess fluid gently removed, and the hearts 
were placed in a drying oven for 48 hours. At that time, 
hearts were removed and weighed. Data were obtained 
from seven to nine hearts for each perfusate as controls 
and for each ischemic interval. 
Systolic function. The intraventricular balloon was 
filled with a volume of saline to produce an end-diastolic 
pressure of 10 mm Hg. Isovolumic developed pressure at 
this preload (millimeters of mercury) was calculated as the 
difference between peak left ventricular systolic pressure 
and this diastolic pressure. 
Coronary flow. Three-minute timed collection of coro- 
nary venous efftuent was made at each sampling interval. 
Results were expressed as milliliters per minute per gram 
dry weight of the heart. 
Statistical methods. Data are presented as mean _+ 
standard error of the mean. Paired observations were 
compared by Student's t test. Repeated observations were 
compared by analysis of variance with Tukey's method 
used to adjust for multiple tests. Differences were consid- 
ered significant ifp was -< 0.05. 
Results 
Systolic function (Table I). Krebs-perfused 
hearts had no decrement in developed pressure 
after the 10- and 20-minute ischemic intervals. How- 
ever, the 72% and 64% returns of preischemic 
developed pressure after 30 and 45 minutes of  
ischemia were depressed (p < 0.05 for each) com- 
pared with control values. In blood-perfused hearts, 
there was an incremental decrease in developed 
pressure after 20 minutes and longer ischemic inter- 
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Fig. 1. Comparison of unstimulated coronary flow in the experimental groups. With Krebs perfusate, 28% 
to 42% increases were noted following after 10 to 30 minutes of ischemia, whereas with blood perfusate no 
significant hyperemia was noted 45 minutes after the progressive ischemic intervals. 
Table II. Coronary flow patterns during the expermental protocol 
After ischemia 
Before ischemia 10 min 20 min 30 min 45 min 
Basal CF (ml/min per gram 
dry weight) 
Krebs 32.4 _+ 2.1 42.5 _+ 2.3* 46.0 + 2.1" 41.4 --_ 1.0" 36.8 ± 4.2 
Blood 5.5 ± 1.6 7.7 _+ 0.8 5.4 _+ 0.7 4.9 _+ 0.2 4.4 _+ 0.9 
Increase in CF (ml/min per 
gram dry weight) 
Krebs-BK 7.5 _+ 1.5 5.8 + 1.6 3.1 ___ 1.9" 0.2 _+ 0.2* 1.9 _+ 0.6* 
Blood-BK 4.4 _+ 1.4 7.4 _+ 0.99 6.6 ± 1.3 5.9 --- 1.4 6.0 ___ 1.2 
Krebs-NTG 6.5 _+ 1.3 3.8 ± 2.2 1.6 --- 1.1 0.3 -+ 0.5* 2.6 ,,, 0.6* 
Blood-NTG 4.2 _+ 0.8 4.5 -_+ 1.1 3.4 ± 0.8 3.6 ± 0.5 3.8 --- 1.1 
Values are mean -4- standard error of the mean; n = 7 to 9 hearts per group; CF, coronary flow; BK, bradykinin 1nmol; NTG, 500 t~g nitroglycerin. 
*p < 0.05 versus before ischernia. 
vals that reached significance after 30 and 45 min- 
utes of ischemia with reperfusion (74% and 72%, 
respectively, p < 0.05 versus control for each). A 
similar pattern of maximum +dp/dt was noted, 
declining to 63% and 72% of control in Krebs- and 
blood-perfused hearts, respectively, after 45 minutes 
of ischemia (p < 0.05, each group). No difference in 
the two parameters of systolic function was noted in 
comparing Krebs- and blood-perfused hearts before 
and after each ischemic interval. Because heart rate 
was fixed by pacing, the mechanical determinants of
coronary flow were comparable in the two groups 
throughout the experimental protocol. 
Basal eoronary flow (Table II, Fig. 1). In Krebs- 
perfused hearts, control unstimulated coronary flow 
ranged between 21.3 and 48.2 ml/min per gram dry 
weight whereas blood-perfused hearts had coronary 
flow between 3.6 and 8.2 ml/min per gram dry 
weight. After ischemia and equilibration, coronary 
hyperemia persisted for Krebs-perfused hearts sub- 
jected to all but the longest ischemic interval (p < 
0.05 versus control for 10, 20, and 30 minutes of 
ischemia, respectively). When measured after the 
45-minute quilibration period, unstimulated coro- 
nary flow after all ischemic intervals in blood- 
perfused hearts was unchanged from preischemic 
flow. A comparison of the groups at each study 
interval showed that coronary flow in Krebs-per- 
fused hearts was 5.5- to 8.5-fold greater than in 
blood-perfused hearts (p < 0.001, all intervals). 
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Fig. 2. Comparison of endothelium-dependent coronary flow reserve in the experimental groups quanti- 
tated by percentage increase over basal flow in response to bradykinin (B/~ 1 nmol). 
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Fig. 3. Comparison of endothelium-independent coronary flow reserve in the experimental groups 
quantitated by percentage increase over basal flow in response to nitroglycerin (NTG, 500 txg). 
Coronary flow reserve (Table II, Figs. 2 to 4). 
Before ischemia, bradykinin and nitroglycerin in- 
creased coronary flow by 7.5 +_ 1.5 and 6.5 _+ 1.3 
tal/min per gram dry weight in Krebs-perfused 
hearts and 4.4 _ 1.4 and 4.2 -+ 0.8 ml/min per gram 
dry weight in blood-perfused hearts. The percentage 
increase over unstimulated coronary flow was al- 
most identical for each agonist within each group, 
but the magnitude of this increase was almost 
fourfold greater with blood perfusion (p < 0.001). In 
Krebs-perfused hearts, the responses to bradykinin 
and nitroglycerin were comparable after each of the 
ischemic intervals. The percentage increase over 
unstimulated flow was less than 10 minutes of 
ischemia, and no significant augmentation in coro- 
nary flow was inducible after the longer ischemic 
intervals. In contrast, the 98% to 130% and 67% to 
87% increases in coronary flow stimulated by bra- 
dykinin and nitroglycerin, respectively, after graded 
ischemic insults in blood-perfused hearts did not 
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Fig. 4. Comparison of endothelium-dependent v rsus endothelium-independent coronary flow reserve in 
blood-perfused hearts quantitated by percentage increase over basal flow in response to bradykinin (BK, 
1 nmol) and nitroglycerin (NTG, 500/zg). 
differ from preischemic coronary flow reserve. The 
response to a given agonist was unaffected by isch- 
emic time; however, for ischemic durations of 20 
minutes or longer, the magnitude of the response to 
bradykinin was greater than that to nitroglycerin 
(p < 0.05). 
Myoeardial water eontent. For Krebs-perfused 
hearts, control myocardial water content was 
85.9% -- 1.3%. After the various ischemic intervals, 
heart water content ranged from 85.4% to 86.5% 
and did not differ from control or in relation to 
ischemic interval. Blood-peffused hearts had 80.4% 
- 0.9% water content before ischemia, and after the 
protocol intervals water content ranged from 78.1% 
to 81.3%, again not different from control or in 
relation to ischemia. However, the Krebs-perfused 
hearts had significantly more water content than 
blood-perfused hearts at each study interval (p < 
0.01, each interval). 
Diseussion 
Conceptually, we have performed an experiment 
in an isolated small animal heart preparation to 
quantitate derangements in resting coronary flow 
and stimulated endothelium-dependent a dendo- 
thelium-independent coronary flow reserve to incre- 
mentally more severe ischemic insults. We com- 
pared the relative susceptibility to unprotected, 
global normothermic ischemia of these coronary 
flow patterns with isovolumic systolic performance. 
Given an identical experimental protocol, implica- 
tions from the data generated epend on whether 
the heart was peffused with homologous blood or an 
asanguineous solution. In a blood-perfused heart, 
systolic performance was compromised, but the 
response to bradykinin and nitroglycerin was unaf- 
fected even after the longest ischemic interval, sug- 
gesting resistance of the endothelium and coronary 
arterial smooth muscle to ischemia-reperfusion n- 
jury. In contrast, in Krebs-perfused hearts, the re- 
sponse to these agonists was blunted before a dec- 
rement in systolic function was noted. Does this 
imply that the coronary vasculature including the 
endothelium is more susceptible than the myocyte 
to deprivation of flow? Alternatively, does the high 
shear stress of the unphysiologic resting coronary 
flow in the crystalloid-perfused heart result in al- 
most maximal relaxation of arterial smooth muscle 
mediated by endothelium-derived relaxing factor 
(EDRF), thus precluding an incremental effect 
when an exogenous agonist is infused? 
When conflicting interpretations exist, confirma- 
tion of alternative xplanations i  sought in the litera- 
rare. Unfortunately, the various methods for quanti- 
tating coronary artery endothelial cell and smooth 
muscle dysfunction after ischemia may further obfus- 
cate rather than clarify the issue. »-8 For instance, 
"endothelial function" can be tested in vivo by infusion 
of agonists to stimulate ndothelial muscarinic, sero- 
tonergic, purinergic, thrombin, or vasopressinergic re-
ceptor-mediated EDRF release. EDRF causes relax- 
ation of the underlying smooth muscle by a mechanism 
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that involves cyclic guanosine monophosphate-depen- 
dem protein phosphorylation. What is usually mea- 
sured is a change in coronary flow or resistance 
resulting ffom this vasodilation. Differences in dosage, 
agonist, and species make strict comparison ditficult. 
Altematively, ex vivo methods use harvested rings of 
epicardial vessels. Comparative arterial vascular e- 
sponsiveness, that is, force of contraction, is quanti- 
tated by adding agonists to the bath with the endothe- 
lium intact or denuded and/or in the resting state or 
preconstricted. The lack of "gold standards" applica- 
ble to all laboratories i evident. Moreover, these ex 
vivo tests of vascular esponsiveness are performed in 
epicardial conductance v ssels, whereas the effects of 
an in vivo infusion of vasoactive agent are more likely 
at the coronary arteriolar level. 
Several studies, mostly involving isolated canine 
epicardial coronary arterial rings, suggest that brief 
ischemia results in vascular endothelial dysfunction. 
Gross and colleagues 9 showed attenuated endothe- 
lium-dependent responses after repetitive 5-minute 
occlusions but unaftected response to endothelium- 
independent agonists. After 15 minutes of ischemia, 
Headrick, Angello, and Berne 1° showed injury to 
the large coronary conduit vessels and Dauber and 
coworkers 11 also showed concomitant microvascular 
damage. The time course of recovery of this 
' stunned" endothelial function has been assessed by 
Kim and colleaguesJ 2 After 15 minutes of ischemia, 
the impaired vasodilatory response to acetylcholine 
required 90 minutes to return to baseline. The 
response to nitroprusside was unaffected by their 
protocol. In vitro endothelium-dependent vasodila- 
tory responses were blunted after 10 minutes of 
ischemia, abolished after 20 minutes, and required 
120 minutes of reperfusion to recover. In contrast, 
the in vivo study of McFalls and associates 13found 
no diminution in endothelium-dependent coronary 
flow reserve of swine after 10 minutes of ischemia. 
More easily comparable to the present study is the 
work of Hashimoto and coworkersJ 4 In crystalloid- 
perfused isolated rabbit hearts subjected to 30 min- 
utes of ischemia and 45 minutes of reperfusion, 
serotonin inereased coronary flow 30.5% before 
ischemia nd only 13.4% after ischemia, whereas the 
smooth muscle response to adenosine was unaf- 
fected. Although postischemic systolic dysfunction 
was comparable to our 30-minute ischemic groups, 
the difterence in endothelium-dependent and -inde- 
pendent flow reserve could be attributable to differ- 
ent agonists and lower basal flow rates. Similarly, 
Tsao and Lefer 15 subjected isolated, crystalloid- 
perfused rat hearts to 30 minutes of global ischemia 
and found impaired relaxation to an alternative 
endothelium-dependent vasodilator, acetylcholine, 
after 20 minutes of reperfusion. No change in 
responsiveness to nitroglycerin was noted. However, 
unlike the present study, flow patterns to these 
agonists were quantitated after preconstriction of 
the coronary vaseulature by U4619. 
A detailed review of endothelial and arterial 
smooth muscle function after 1 hour of ischemia or 
more is not applicable to the presented ata. How- 
ever, conflicting results are reported that parallel 
the information available for "reversible ischemic" 
insults, that is, divergence of endothelium-depen- 
dent and -independent responses and actual exis- 
tence of an injury. Representative of these contro- 
versies are the observations by Pearson, Schaft, and 
Vanhoutte,16, 17showing persistence of altered sero- 
tonergic and purinergic receptor activity 1 month 
after a 1-hour ischemic interval. Dignan and associ- 
ates 18 found no vascular injury after 2 hours of 
ischemia, and Viehman and coworkers 19 had to 
extend ischemia to 3 hours to demonstrate impaired 
vasoreactivity. 
This study has several limitations. Admittedly, 
this is a descriptive and not a mechanistic protocol 
and therefore the questions posed in the first para- 
graph of the discussion are not answered. The 
relative contributions of altered viscosity, oxygen 
tension, formed blood cell elements, and wall shear 
stress were not analyzed. The crystalloid-perfused 
studies were purposely performed in a "standard" 
manner to compare with a more physiologic blood 
perfusate, and no attempt was made to control for 
the aforementioned variables. Second, the concen- 
trations of agonist actually presented to the endo- 
thelial receptor may have been lower in the crystal- 
loid-perfused hearts because of the increased 
resting coronary flow. However, preliminary dose- 
response curves (data not shown) in both crystalloid 
and blood perfusates showed maximal response to 
the concentration of agonist infused by bolus injec- 
tion. Therefore, we support he quantitative validity 
of these observations and propose that despite the 
simplicity of a crystalloid-perfused heart model, it is 
inappropriate for assessment of the interaction be- 
tween coronary flow reserve and ischemic injury. 
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